- Home
- Articles
-
10.5606/tgkdc.dergisi.2012.177
Methylenetetrahydrofolate reductase polymorphism in a case with atrial septal defect, deep venous thrombosis, thromboembolism and recurrent spontaneous abortion
Adem Güler1, Mehmet Ali Şahin1, Murat Tavlaşoğlu1, Mehmet Yokuşoğlu2
1Department of Cardiovascular Surgery, Gülhane Military Medical School, Ankara, Turkey
2Department of Cardiology, Gülhane Military Medical School, Ankara, Turkey
DOI : 10.5606/tgkdc.dergisi.2012.177
Methylenetetrahydrofolate reductase (MTHFR) is a key
enzyme in the folate metabolism, where homocysteine
converted to methionine. Methylenetetrahydrofolate
reductase gene polymorphism is responsible for
hyperhomocysteinemia resulting congenital heart defects,
hypercoagulable states and recurrent abortion. A 30-yearold
female was referred to our department with the
diagnosis of atrial septal defect. In her medical history,
she had two pregnancies with spontaneous abortus, deep
venous thrombosis attacks, pulmonary thromboembolism
and paradoxical cerebral embolus. The genetic workup
revealed heterozygote MTHFR C677T mutation. We
recommend suspecting MTHFR polymorphism in young
fertile women with a history of spontaneous abortus or
deep venous thrombosis or congenital heart disease with a
paradoxical cerebral embolus.
Keywords : Atrial septal defect; deep venous thrombosis; methylenetetrahydrofolate reductase; spontaneous abortion; thromboembolism
Viewed : 9322
Downloaded : 2304